A key expert panel recommended Thursday the Food and Drug Administration authorize the COVID-19 vaccine developed by Moderna, which in trials was shown to be safe and 94.5% effective. The FDA is expected to act quickly, with doses potentially reaching states next week. | |
News Alert Thursday, December 17 |
|
| | | | |
|